AquaBounty Technologies, Inc., a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was founded in 1991 and is headquartered in Maynard, Massachusetts. AquaBounty Technologies, Inc. is a subsidiary of Intrexon Corporation.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone978-648-6000
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees39
Next Earnings DateN/A
OptionableNot Optionable
AquaBounty Technologies (NYSE:AQB) Frequently Asked Questions
What is AquaBounty Technologies' stock symbol?
AquaBounty Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "AQB."
How were AquaBounty Technologies' earnings last quarter?
AquaBounty Technologies (NYSE:AQB) released its quarterly earnings results on Tuesday, August, 6th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.13) by $0.06. The firm earned $0.04 million during the quarter, compared to analyst estimates of $0.01 million. View AquaBounty Technologies' Earnings History.
What price target have analysts set for AQB?
1 brokerages have issued 1-year price objectives for AquaBounty Technologies' stock. Their predictions range from $5.50 to $5.50. On average, they expect AquaBounty Technologies' stock price to reach $5.50 in the next year. This suggests a possible upside of 108.3% from the stock's current price. View Analyst Price Targets for AquaBounty Technologies.
What is the consensus analysts' recommendation for AquaBounty Technologies?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AquaBounty Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AquaBounty Technologies.
Has AquaBounty Technologies been receiving favorable news coverage?
Media headlines about AQB stock have trended positive recently, according to InfoTrie. The research firm scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. AquaBounty Technologies earned a coverage optimism score of 2.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for AquaBounty Technologies.
Who are some of AquaBounty Technologies' key competitors?
Some companies that are related to AquaBounty Technologies include Exicure (XCUR), Enochian Biosciences (ENOB), Bioventix (BVXP), IMV (IMV), Silence Therapeutics (SLN), Senesco Technologies (ELOX), Arix Bioscience (ARIX), Cynata Therapeutics (CYP), Ampliphi Biosciences (APHB), BioTime (BTX), BioTime (BTX), Emerald Health Therapeutics (EMH), Ergomed (ERGO), MediGene (MDG1) and CorMedix (CRMD).
What other stocks do shareholders of AquaBounty Technologies own?
Who are AquaBounty Technologies' key executives?
AquaBounty Technologies' management team includes the folowing people:
- Mr. David A. Frank, CFO & Treasurer (Age 59)
- Dr. Ronald L. Stotish, Chief Technology Officer (Age 70)
- Mr. Alejandro Rojas, Chief Operating Officer of Aquabounty Farms (Age 57)
- Ms. Sylvia Wulf, CEO, Pres & Exec. Director (Age 61)
- Mr. Christopher H. Martin, Gen. Counsel & Company Sec. (Age 53)
How do I buy shares of AquaBounty Technologies?
Shares of AQB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is AquaBounty Technologies' stock price today?
One share of AQB stock can currently be purchased for approximately $2.64.
How big of a company is AquaBounty Technologies?
What is AquaBounty Technologies' official website?
How can I contact AquaBounty Technologies?
The company can be reached via phone at 978-648-6000.
MarketBeat Community Rating for AquaBounty Technologies (NYSE AQB)
MarketBeat's community ratings are surveys of what our community members think about AquaBounty Technologies and other stocks. Vote "Outperform" if you believe AQB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AQB will underperform the S&P 500 over the long term. You may vote once every thirty days.
